Evidence map›Paper›PMID 34586780›Full record

ArticleACS nano2021

Apolipoprotein Mimetic Peptide Inhibits Neutrophil-Driven Inflammatory Damage via Membrane Remodeling and Suppression of Cell Lysis.

Michelle W Lee, Elizabeth Wei-Chia Luo, Carlos Silvestre-Roig, Yashes Srinivasan, Kiyotaka Akabori, Patricia Lemnitzer, Nathan W Schmidt, Ghee Hwee Lai, Christian D Santangelo, Oliver Soehnlein and 1 more

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 4 countries.

Michelle W LeeDepartment of Bioengineering, University of California, Los Angeles, California 90095, United States.ORCID 0000-0003-1613-9501
Elizabeth Wei-Chia LuoDepartment of Bioengineering, University of California, Los Angeles, California 90095, United States.ORCID 0000-0002-8663-0446
Carlos Silvestre-RoigInstitute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, 48149 Münster, Germany.
Yashes SrinivasanDepartment of Bioengineering, University of California, Los Angeles, California 90095, United States.ORCID 0000-0002-5279-9753
Kiyotaka AkaboriDepartment of Physics, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Patricia LemnitzerInstitute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, 48149 Münster, Germany.
Nathan W SchmidtDepartment of Bioengineering, University of California, Los Angeles, California 90095, United States.
Ghee Hwee LaiDepartment of Bioengineering, University of California, Los Angeles, California 90095, United States.
Christian D SantangeloDepartment of Physics, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Oliver SoehnleinInstitute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, 48149 Münster, Germany.
Gerard C L WongDepartment of Bioengineering, University of California, Los Angeles, California 90095, United States.ORCID 0000-0003-0893-6383
University of California, Los Angeles · USUniversity of Münster · DEUniversity of Massachusetts Amherst · US

Funding

A Synchrotron Radiation Structural Biology ResourcesP30GM133894 · NIGMS · STANFORD UNIVERSITY · PI Ritimukta Sarangi · 2020 to 2026
$43.3M
Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
NIAID NIH HHS R01 AI052453NIAID NIH HHS R37 AI052453NIGMS NIH HHS P30 GM133894
6 · The paper itself

Abstract

Neutrophils are crucial for host defense but are notorious for causing sterile inflammatory damage. Activated neutrophils in inflamed tissue can liberate histone H4, which was recently shown to perpetuate inflammation by permeating membranes via the generation of negative Gaussian curvature (NGC), leading to lytic cell death. Here, we show that it is possible to build peptides or proteins that cancel NGC in membranes and thereby suppress pore formation, and demonstrate that they can inhibit H4 membrane remodeling and thereby reduce histone H4-driven lytic cell death and resultant inflammation. As a demonstration of principle, we use apolipoprotein A-I (apoA-I) mimetic peptide apoMP

Indexed as

Extracellular TrapsNeutrophilsCell DeathHistonesPeptidesHistonesPeptidesapolipoproteincell deathchronic inflammationmembrane remodelingneutrophilspeptide−membrane interactions

Identifiers

PMID34586780
PMCPMC8720511
OpenAlexW3203745194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.